Getinge AB (publ) (STO:GETI.B)
Sweden · Delayed Price · Currency is SEK 195.85
+3.90 (2.03%)
Apr 14, 2026, 3:20 PM CET
Getinge AB Market Cap
Getinge AB has a market cap or net worth of 52.28 billion as of April 14, 2026. Its market cap has decreased by -13.92% in one year.
Market Cap
52.28B
Enterprise Value
59.83B
Revenue
34.97B
Ranking
n/a
PE Ratio
23.15
Stock Price
195.85
Market Cap Chart
Since March 15, 1996, Getinge AB's market cap has increased from 15.22B to 52.28B, an increase of 243.59%. That is a compound annual growth rate of 4.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 52.28B | -12.27% |
| Dec 30, 2025 | 59.59B | 20.52% |
| Dec 30, 2024 | 49.45B | -19.06% |
| Dec 29, 2023 | 61.09B | 3.70% |
| Dec 30, 2022 | 58.91B | -45.25% |
| Dec 30, 2021 | 107.61B | 105.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sectra AB | 46.20B |
| Elekta AB | 21.15B |
| Nolato AB | 13.93B |
| Vitrolife AB | 13.45B |
| Xvivo Perfusion AB | 8.43B |
| MedCap AB | 7.31B |
| CellaVision AB | 3.57B |
| BICO Group AB | 1.29B |